Florence Jouan

Inserm — France

Medicine · Health Sciences

18h-index1.4kcitations66works1.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(25), Renal and related cancers(17), Cancer Genomics and Diagnostics(8), Cancer, Hypoxia, and Metabolism(7), Epigenetics and DNA Methylation(5)

Publications66 total

Lymphoma B cells remodel bone marrow stromal cells into extracellular matrix–producing cancer-associated fibroblasts
Blood Advances·2025· 2 citedOpen Access
Afatinib or Bevacizumab in combination with Osimertinib efficiently control tumor development in orthotopic murine models of non-small lung cancer
PLoS ONE·2024· 1 citedOpen Access
KDM6B drives epigenetic reprogramming associated with lymphoid stromal cell early commitment and immune properties
Science Advances·2023· 5 citedOpen Access
Lymphoma B cells remodel bone marrow stromal cell organization and function to induce a supportive cancer-associated fibroblast network
2023Open Access
Supplementary Materials and Methods, Supplementary Figures 1-7, Supplementary Tables 1-2 from CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma
2023Open Access
Supplementary Materials and Methods, Supplementary Figures 1-7, Supplementary Tables 1-2 from CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma
2023Open Access
Data from CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma
2023Open Access
Data from CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma
2023Open Access
Genomic characteristics and clinical significance of CD56+ circulating tumor cells in small cell lung cancer
Scientific Reports·2023· 4 citedOpen Access
Dual <scp>IRE1 RNase</scp> functions dictate glioblastoma development
EMBO Molecular Medicine·2023· 7 citedOpen Access
Genomic characteristics and clinical significance of CD56+ Circulating Tumor Cells in Small Cell Lung Cancer
2022· 1 citedOpen Access
Dual IRE1 RNase functions dictate glioblastoma development
EMBO Molecular Medicine·2022· 15 citedOpen Access
Fam72a enforces error-prone DNA repair during antibody diversification
Nature·2021· 55 cited
UnAIDed Class Switching in Activated B-Cells Reveals Intrinsic Features of a Self-Cleaving IgH Locus
Frontiers in Immunology·2021· 6 citedOpen Access
Diverse B-cell specific transcriptional contexts of the BCL2 oncogene in mouse models impacts pre-malignant development
2021Open Access
ING2 tumor suppressive protein translocates into mitochondria and is involved in cellular metabolism homeostasis
Oncogene·2021· 10 cited
P11.61 Development of a novel preclinical GBM model and therapeutic impact of IRE1 inhibition
Neuro-Oncology·2019· 1 citedOpen Access
Synthesis of peptidomimetics and chemo-biological tools for CD95/PLCγ1 interaction analysis
Bioorganic & Medicinal Chemistry Letters·2019· 2 citedOpen Access
IRE1-UBE2D3 signaling controls the recruitment of myeloid cells to glioblastoma
2019· 4 cited
Disrupting the CD95–PLCγ1 interaction prevents Th17-driven inflammation
Nature Chemical Biology·2018· 34 cited
page 1 of 4Next →

Frequent Co-authors

N. Costedoat‐Chalumeau(17), Cécile Vigneau(14), Raphaël Pineau(11), Patricia Fergelot(11), Yannick Arlot‐Bonnemains(9), Tony Avril(9), Éric Chevet(9), G. Verhoest(8), Gwénaële Jégou(8), Pierre‐Jean Le Reste(8), Julien Edeline(8), Jean‐Jacques Patard(8), Joanna Obacz(7), Élodie Vauléon(7), Véronique Quillien(7), Pascale Bellaud(7), Karim Bensalah(6), Amandine Etcheverry(6), Jean Mosser(6), Aristotelis Chatziioannou(6)